Drug recall D-0100-2023
Product
Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06
Reason for recall
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
Lots and codes
Lot # A200171, Exp 12/2023
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 16,056 30 count bottles
- Distribution
- Distributed Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 12, 2022
- Terminated
- January 31, 2024
Related products
- Rifampin – drug information
- NDC 68180-658 Rifampin · Rifampin 150 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-659 Rifampin · Rifampin 300 mg/1 · Lupin Pharmaceuticals, Inc.